Ackman Welcomes SEC Probe As IRS Targets ValeantMark Melin
Bill Ackman welcomes a Securities and Exchange investigation into Pershing Square Capital Management LP and its involvement with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) in the hostile takeover bid of Allergan, Inc. (NYSE:AGN).
This content is exclusively for paying members. Sign up here
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click chat